In Reply-Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia
Mayo Clin Proc
.
2018 Apr;93(4):542.
doi: 10.1016/j.mayocp.2017.12.023.
Authors
Jesper Smit
1
,
Henrik Carl Schønheyder
2
,
Henrik Nielsen
2
,
Mette Søgaard
2
,
Luis Eduardo López-Cortés
3
,
Jesús Rodríguez-Baño
3
,
Reimar Wernich Thomsen
4
,
Trine Frøslev
4
Affiliations
1
Aalborg University Hospital, Aalborg, Denmark; Aarhus University, Aarhus, Denmark.
2
Aalborg University Hospital, Aalborg, Denmark.
3
Universidad de Sevilla, Sevilla, Spain.
4
Aarhus University, Aarhus, Denmark.
PMID:
29622103
DOI:
10.1016/j.mayocp.2017.12.023
No abstract available
Publication types
Letter
Comment
MeSH terms
Bacteremia
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Staphylococcal Infections
Staphylococcus aureus*
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors